EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY-NC 4.0

Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay

Ingar Ziad Restan iD, Ole-Thomas Steiro iD, John W Pickering iD, Hilde L Tjora iD, Jørund Langørgen iD, Torbjørn Omland iD, Paul Collinson iD, Rune Bjørneklett iD, Kjell Vikenes iD, Trude Steinsvik iD, Øyvind Skadberg iD, Øistein R Mjelva und 3 weitere

European Heart Journal: Acute Cardiovascular Care · 2025

DOI: 10.1093/ehjacc/zuaf017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Ingar Ziad Restan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Stavanger University Hospital, Stavanger, Norway. Hauptthemen laut MEDLINE: Algorithms, Troponin I, Myocardial Infarction, Non-ST Elevated Myocardial Infarction. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Western Norway Regional Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This prospective, two-centre study derived and validated predictive algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I (hs-cTnI) assay in the emergency department (ED). Methods and results Algorithms for predicting 30-day myocardial infarction (MI) Types 1 and 2 and death or non-ST-elevation MI (NSTEMI, Types 1 and 2) at index admission were developed from a derivation cohort of 1896 patients and validated using a synthetic data set with nearly 1 million patient cases. Performance was compared with the European Society of Cardiology algorithms for hs-cTnT (Roche Diagnostics) and hs-cTnI (Abbott Diagnostics). An admission hs-cTnI concentration < 5 ng/L had a negative predictive value (NPV) and sensitivity for 30-day MI or death of 99.5–99.7% and 98.1–98.8%, respectively, in the derivation cohort and validation data set. The NPV and sensitivity were ≥99.7% and ≥98.8% for ruling out index NSTEMI. A 0- to 1-h algorithm with baseline hs-cTnI concentration < 10 ng/L and Δ change < 3 ng/L had NPV of ≥99.5% and sensitivity ≥ 97.3% for predicting 30-day MI or death and a ≥99.5% sensitivity and NPV for index NSTEMI. Rule-in algorithms of either 0-h hs-cTnI ≥ 120 ng/L or 0- to 1-h Δ change ≥ 12 ng/L had positive predictive value ≥ 73% and specificity > 96% for 30-day MI or death and index NSTEMI. The results were comparable with established hs-cTn algorithms.

Conclusion

This study presents Siemens Atellica hs-cTnI algorithms for diagnosis and risk prediction in the ED with performance comparable with established hs-cTnT (Roche) and hs-cTnI (Abbott) algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsTroponin IMyocardial InfarctionNon-ST Elevated Myocardial InfarctionHumansFemaleProspective StudiesMaleAgedBiomarkersPredictive Value of TestsEmergency Service, HospitalMiddle AgedPrognosis

Stichwörter der Autor:innen

Acute coronary syndromeDeathHigh-sensitivity cardiac troponinMyocardial infarctionNSTEMINon-ST-elevation myocardial infarctionSiemens Atellica IM hs-cTnISimulated patientsSynthetic validation

Substanzen

Troponin IBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.
  • Department of Heart Disease, Haukeland University Hospital, P.O. Box 1400, NO-5021 Bergen, Norway.
  • Department of Medicine, Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
  • Emergency Care Foundation, Christchurch Hospital, Christchurch, New Zealand.
  • Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway.
  • Department of Cardiology, Akershus University Hospital, Oslo, Norway.

ORCID-Profile: Ingar Ziad Restan, Ole-Thomas Steiro, John W Pickering, Hilde L Tjora, Jørund Langørgen, Torbjørn Omland, Paul Collinson, Rune Bjørneklett, Kjell Vikenes, Trude Steinsvik, Øyvind Skadberg, Alf Inge Larsen, Vernon V S Bonarjee, Kristin M Aakre

Förderung

  • Western Norway Regional Health Authority

Zitieren

APA

Restan, I. Z., Steiro, O. T., Pickering, J. W., Tjora, H. L., Langørgen, J., Omland, T., Collinson, P., Bjørneklett, R., Vikenes, K., Steinsvik, T., Skadberg, Ø., Mjelva, Ø. R., Larsen, A. I., Bonarjee, V. V. S., & Aakre, K. M. (2025). Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuaf017

Vancouver

Restan IZ, Steiro OT, Pickering JW, Tjora HL, Langørgen J, Omland T, et al. Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuaf017

BibTeX
@article{Restan2025,
  author = {Restan, Ingar Ziad and Steiro, Ole-Thomas and Pickering, John W and Tjora, Hilde L and Langørgen, Jørund and Omland, Torbjørn and Collinson, Paul and Bjørneklett, Rune and Vikenes, Kjell and Steinsvik, Trude and Skadberg, Øyvind and Mjelva, Øistein R and Larsen, Alf Inge and Bonarjee, Vernon V S and Aakre, Kristin M},
  title = {Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2025},
  doi = {10.1093/ehjacc/zuaf017}
}
Kostenlos starten →